cediranib

[email protected]
cediranib
Trade Name
Orphan Indication Glioblastoma
USA Market Approval USA
USA Designation Date 2010-12-13 00:00:00
Sponsor National Institutes of Health;National Cancer Institute, 9609 Medical Center Dr.;Bethesda, Maryland, 20892
Related Access Program
Center Trials & Treatment – Glioblastoma by Gene Expression Profile Center Trials & Treatment – Glioblastoma Multiforme Northwest Biotherapeutics – Glioblastoma Multiforme Northwest Biotherapeutics – Glioblastoma Celldex Therapeutics – Recurrent GBM